Acne

John Barbieri, MD, MBA, FAAD, speaking in his capacity as a member of the AADA iPLEDGE Workgroup, talks with Dermatology Times® about the recent iPLEDGE website struggles and guidance on how dermatologists should handle the situation.

Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/SGM Expert Resource Group, sits down with Dermatology Times® to discuss what changes were made to the iPLEDGE platform, examples of how the roll out has been unsuccessful, and how patients should be wary of trying to take old medications.

In this video interview, Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/SGM Expert Resource Group, explains what happened with the iPLEDGE website.

A study investigated the acceptability and validity of patient-reported outcome measures for adult acne, comparing them to the validated acne-specific quality-of-life measure.

Click here to answer this week's poll.

This letter to the editor in the Journal of the American Academy of Dermatology investigated how mental health and its association to race and ethnicity relate to patients with acne.

Here is what to expect from the “Getting to the Roots of Childhood Acne” live virtual webinar happening December 15 at 6:30 p.m.

In this week’s Pointers with Dr Portela, the 208SkinDoc answers viewer questions about acne scarring including how to distinguish between acne scars and inflammatory pigment change.

Twenty four international plastic surgeons and dermatologists came together to provide a consensus on the treatment of acne scars.

In this week’s Pointers with Dr Portela, the 208SkinDoc reviews the Clear Start Acne kit and takes a deep dive on the ingredients in the products.

A study in the Journal of the American Academy of Dermatology investigated Instagram’s content on acne and its quality.

This study aimed to examined morbidity associated with truncal acne.

In this exclusive interview with Dermatology Times, David Goldberg, MD, JD, explains why lasers are a treatment option in acne and the latest advancements in the field.

In this exclusive video interview with Dermatology Times, Michael Gold, MD, tells us about his session at the New Frontiers in Cosmetic Medicine and Medical Dermatology Symposium.

Sun Pharma has announced that their Winlevi 1% cream is now available in the US to treat acne vulgaris in patients 12 years and older.

Racial disparities in antibiotic prescription also influence treatment decisions.

A study investigated the role diet habits have in the development, duration, and severity of acne.

Two published studies investigated the safety and efficacy of oral sarecycline for the treatment of truncal acne.

Which is more worrisome, neonatal or infantile acne? An expert answered this question and more during Maui Derm NP+PA Fall 2021’s update on acne and rosacea.

A recent case report highlights the importance of caution when using fractional laser resurfacing in patients with active or previous acne.

In this week’s Pointers with Dr Portela, the 208SkinDoc and Cassandra Bankson, a medical aesthetician and skin advocate, react to cystic acne TikToks and offer commentary.

At the 2021 Skin of Color Update, Andrew Alexis, MD, MPH, presented on the subtle distinctions in treating skin of color patients with acne.

Click here to answer our weekly poll.

This week’s Pointers With Dr Portela, Dustin Portela, DO, explains pimple patches and hydrocolloid patches, diving into how to treat acne when it surfaces.

Testosterone therapy often leads to unique challenges.

A review article investigated the psychological effects acne has on adolescent patients.

A survey conducted by Acne Wipeout and OnePoll found that Americans miss out on dating, school, hanging out with friends, and work meetings because of their skin.

A recent study investigated the difference between skin microbiota in patients with acne and controls without acne.

A study published in JAMA Dermatology investigated the strain acne puts on the lives of adult women.

Joshua Zeichner, MD, associate professor of dermatology and director of cosmetic & clinical research in dermatology, Mount Sinai Hospital, New York, discusses the impact of the recent FDA approval of Twyneo (Sol-Gel) for the treatment of acne.